Search Results - "Desai, Niraj M"

Individual Frailty Components and Mortality in Kidney Transplant Recipients by McAdams-DeMarco, Mara A, Ying, Hao, Olorundare, Israel, King, Elizabeth A, Haugen, Christine, Buta, Brian, Gross, Alden L, Kalyani, Rita, Desai, Niraj M, Dagher, Nabil N, Lonze, Bonnie E, Montgomery, Robert A, Bandeen-Roche, Karen, Walston, Jeremy D, Segev, Dorry L

“…BACKGROUNDFrailty increases early hospital readmission and mortality risk among kidney transplantation (KT) recipients. Although frailty represents a high-risk…”
Get full text

Frailty and Access to Kidney Transplantation by Haugen, Christine E, Chu, Nadia M, Ying, Hao, Warsame, Fatima, Holscher, Courtenay M, Desai, Niraj M, Jones, Miranda R, Norman, Silas P, Brennan, Daniel C, Garonzik-Wang, Jacqueline, Walston, Jeremy D, Bingaman, Adam W, Segev, Dorry L, McAdams-DeMarco, Mara

“…Frailty, a syndrome distinct from comorbidity and disability, is clinically manifested as a decreased resistance to stressors and is present in up to 35% of…”
Get full text

Frailty and Postkidney Transplant Health-Related Quality of Life by McAdams-DeMarco, Mara A, Olorundare, Israel O, Ying, Hao, Warsame, Fatima, Haugen, Christine E, Hall, Rasheeda, Garonzik-Wang, Jacqueline M, Desai, Niraj M, Walston, Jeremy D, Norman, Silas P, Segev, Dorry L

“…BACKGROUNDHealth-related quality of life (HRQOL) reflects a patient’s disease burden, treatment effectiveness, and health status and is summarized by physical,…”
Get full text

Center-Level Factors and Racial Disparities in Living Donor Kidney Transplantation by Hall, Erin C., MD, MPH, James, Nathan T., ScM, Garonzik Wang, Jacqueline M., MD, Berger, Jonathan C., MD, MHS, Montgomery, Robert A., MD, DPhil, Dagher, Nabil N., MD, Desai, Niraj M., MD, Segev, Dorry L., MD, PhD

“…Background On average, African Americans attain living donor kidney transplantation (LDKT) at decreased rates compared with their non–African American…”
Get full text

Survival following liver transplantation from non-heart-beating donors by ABT, Peter L, DESAI, Niraj M, CRAWFORD, Michael D, FORMAN, Lisa M, MARKMANN, Joseph W, OLTHOFF, Kim M, MARKMANN, James F

“…To determine whether patient and graft survival following transplantation with non-heart-beating donor (NHBD) hepatic allografts is equivalent to…”
Get full text

Pre-Liver Transplantation Locoregional Adjuvant Therapy for Hepatocellular Carcinoma as a Strategy to Improve Longterm Survival by Bharat, Ankit, Brown, Daniel B., Crippin, Jeffrey S., Gould, Jennifer E., Lowell, Jeffrey A., Shenoy, Surendra, Desai, Niraj M., Chapman, William C.

“…Preorthotopic liver transplantation locoregional therapy (LRT) for hepatocellular carcinoma (HCC) reduces drop-out rates in patients awaiting orthotopic liver…”
Get full text

Structural and Functional Abnormalities in the Islets Isolated From Type 2 Diabetic Subjects by SHAOPING DENG, VATAMANIUK, Marko, BARKER, Clyde F, NAJI, Ali, MATSCHINSKY, Franz M, MARKMANN, James F, XIAOLUN HUANG, DOLIBA, Nicolai, LIAN, Moh-Moh, FRANK, Adam, VELIDEDEOGLU, Ergun, DESAI, Niraj M, KOEBERLEIN, Brigitte, WOLF, Bryan

“…Structural and Functional Abnormalities in the Islets Isolated From Type 2 Diabetic Subjects Shaoping Deng 1 , Marko Vatamaniuk 2 3 , Xiaolun Huang 1 , Nicolai…”
Get full text

Outcomes and risk stratification for late antibody-mediated rejection in recipients of ABO-incompatible kidney transplants: a retrospective study by Lonze, Bonnie E, Bae, Sunjae, Kraus, Edward S, Holechek, Mary J, King, Karen E, Alachkar, Nada, Naqvi, Fizza F, Dagher, Nabil N, Sharif, Adnan, Desai, Niraj M, Segev, Dorry L, Montgomery, Robert A

“…The required intensity of monitoring for antibody-mediated rejection (AMR) after of ABO-incompatible (ABOi) kidney transplantation is not clearly formulized…”
Get more information

One-Year Outcomes of the Multi-Center StudY to Transplant Hepatitis C-InfeCted kidneys (MYTHIC) Trial by Sise, Meghan Elizabeth, Goldberg, David Seth, Schaubel, Douglas Earl, Fontana, Robert J., Kort, Jens J., Alloway, Rita R., Durand, Christine M., Blumberg, Emily A., Woodle, E. Steve, Sherman, Kenneth E., Brown, Robert S., Friedewald, John J., Desai, Niraj M., Sultan, Samuel T., Levitsky, Josh, Lee, Meghan D., Strohbehn, Ian A., Landis, J. Richard, Fernando, Melissa, Gustafson, Jenna L., Chung, Raymond T., Reese, Peter Philip

“…Transplanting kidneys from hepatitis C virus (HCV) viremic donors into HCV-negative patients (HCV D-RNA-positive/R-negative) has evolved from experimental to…”
Get full text

Patient and Graft Survival After A1/A2-incompatible Living Donor Kidney Transplantation by Bisen, Shivani S., Getsin, Samantha N., Chiang, Po-Yu, Herrick-Reynolds, Kayleigh, Zeiser, Laura B., Yu, Sile, Desai, Niraj M., Al Ammary, Fawaz, Jackson, Kyle R., Segev, Dorry L., Massie, Allan B.

“…ABO type B and O kidney transplant candidates have increased difficulty identifying a compatible donor for living donor kidney transplantation (LDKT) and are…”
Get full text

Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus-Infected Donors to Noninfected Recipients: An Open-Label Nonrandomized Trial by Durand, Christine M, Bowring, Mary G, Brown, Diane M, Chattergoon, Michael A, Massaccesi, Guido, Bair, Nichole, Wesson, Russell, Reyad, Ashraf, Naqvi, Fizza F, Ostrander, Darin, Sugarman, Jeremy, Segev, Dorry L, Sulkowski, Mark, Desai, Niraj M

“…Given the high mortality rate for patients with end-stage kidney disease receiving dialysis and the efficacy and safety of hepatitis C virus (HCV) treatments,…”
Get full text

Kidney Transplantation Confers Survival Benefit for Candidates With Pulmonary Hypertension by Nguyen, Michelle C., Po-Yu Chiang, Teresa, Massie, Allan B., Bae, Sunjae, Motter, Jennifer D., Brennan, Daniel C., Desai, Niraj M., Segev, Dorry L., Garonzik-Wang, Jacqueline M.

“…Kidney transplantation (KT) is controversial in patients with pretransplant pulmonary hypertension (PtPH). We aimed to quantify post-KT graft and patient…”
Get full text

The Drug Overdose Epidemic and Deceased-Donor Transplantation in the United States: A National Registry Study by Durand, Christine M, Bowring, Mary G, Thomas, Alvin G, Kucirka, Lauren M, Massie, Allan B, Cameron, Andrew, Desai, Niraj M, Sulkowski, Mark, Segev, Dorry L

“…The epidemic of drug overdose deaths in the United States has led to an increase in organ donors. To characterize donors who died of overdose and to analyze…”
Get full text

Serum Sickness After Treatment With Rabbit Antithymocyte Globulin in Kidney Transplant Recipients With Previous Rabbit Exposure by Boothpur, Raghavender, MD, Hardinger, Karen L., PharmD, Skelton, Rebecca M., RN, Lluka, Brunilda, MD, Koch, Matthew J., MD, Miller, Brent W., MD, Desai, Niraj M., MD, Brennan, Daniel C., MD

“…Serum sickness after rabbit antithymocyte globulin administration has a reported incidence of 7% to 27% in kidney transplant recipients. We describe 4 patients…”
Get full text

Frailty, Length of Stay, and Mortality in Kidney Transplant Recipients: A National Registry and Prospective Cohort Study by McAdams-DeMarco, Mara A, King, Elizabeth A, Luo, Xun, Haugen, Christine, DiBrito, Sandra, Shaffer, Ashton, Kucirka, Lauren M, Desai, Niraj M, Dagher, Nabil N, Lonze, Bonnie E, Montgomery, Robert A, Walston, Jeremy, Segev, Dorry L

“…OBJECTIVE:To test whether frailty, a novel measure of physiologic reserve, is associated with longer kidney transplant (KT) length of stay (LOS), and modifies…”
Get full text

Imlifidase Desensitization in Crossmatch-positive, Highly Sensitized Kidney Transplant Recipients: Results of an International Phase 2 Trial (Highdes) by Jordan, Stanley C., Legendre, Christophe, Desai, Niraj M., Lorant, Tomas, Bengtsson, Mats, Lonze, Bonnie E., Vo, Ashley A., Runström, Anna, Laxmyr, Lena, Sjöholm, Kristoffer, Schiött, Åsa, Sonesson, Elisabeth, Wood, Kathryn, Winstedt, Lena, Kjellman, Christian, Montgomery, Robert A.

“…BACKGROUND:Highly-HLA sensitized patients have limited access to life-saving kidney transplantation due to a paucity of immunologically suitable donors…”
Get full text

Frailty, Inflammatory Markers, and Waitlist Mortality Among Patients with End-Stage Renal Disease in a Prospective Cohort Study by McAdams-DeMarco, Mara A, Ying, Hao, Thomas, Alvin G, Warsame, Fatima, Shaffer, Ashton A, Haugen, Christine E, Garonzik-Wang, Jacqueline M, Desai, Niraj M, Varadhan, Ravi, Walston, Jeremy, Norman, Silas P, Segev, Dorry L

“…BACKGROUNDAmong community-dwelling older adults, frailty is associated with heightened markers of inflammation and subsequent mortality. Although frailty is…”
Get full text

Early Changes in Kidney Distribution under the New Allocation System by Massie, Allan B, Luo, Xun, Lonze, Bonnie E, Desai, Niraj M, Bingaman, Adam W, Cooper, Matthew, Segev, Dorry L

“…The Kidney Allocation System (KAS), a major change to deceased donor kidney allocation, was implemented in December 2014. Goals of KAS included directing the…”
Get full text

Lessons from the real world: HCV‐infected donor kidney transplantation as standard practice by Durand, Christine M., Chattergoon, Michael A., Desai, Niraj M.

“…This editorial highlights key practical, clinical, and ethical lessons revealed in Molnar et al's (page 3046) real‐world experience using hepatitis C–infected…”
Get full text

Outcomes at 3 years posttransplant in imlifidase‐desensitized kidney transplant patients by Kjellman, Christian, Maldonado, Angela Q., Sjöholm, Kristoffer, Lonze, Bonnie E., Montgomery, Robert A., Runström, Anna, Lorant, Tomas, Desai, Niraj M., Legendre, Christophe, Lundgren, Torbjörn, Zur Mühlen, Bengt, Vo, Ashley A., Olsson, Håkan, Jordan, Stanley C.

“…Imlifidase is a cysteine proteinase which specifically cleaves IgG, inhibiting Fc‐mediated effector function within hours of administration. Imlifidase…”
Get full text